Biosignatures of Chronic Drug Exposure
Published Date
Agency
CFDA
93.279
Contact Information
Cheryl Nathaniel, 301-443-6710; nathanic@mail.nih.gov
Deadline
Department
Eligiblity
State, local and tribal governments, independent school districts, nonprofit and for-profit organizations, institutions of higher education and public housing authorities
Guide Page Reference
None
Program Area
Programe Purpose
To identify appropriate clinically accessible biomaterial (e.g., blood, lymphocytes, bladder epithelial cells and stem cells) and to identify the best class or classes of molecules (proteins, peptides, RNA, miRNA, etc.) suitable for assay development
